APA (7th ed.) Citation

T, I., T, M., S, B., Y, M., H, K., H, K., . . . T, K. (2024). Safety of immune checkpoint inhibitors in patients aged over 80 years: A retrospective cohort study. Cancer immunology, immunotherapy : CII, 73(7), 126. https://doi.org/10.1007/s00262-024-03707-4

Chicago Style (17th ed.) Citation

T, Ikoma, et al. "Safety of Immune Checkpoint Inhibitors in Patients Aged over 80 Years: A Retrospective Cohort Study." Cancer Immunology, Immunotherapy : CII 73, no. 7 (2024): 126. https://doi.org/10.1007/s00262-024-03707-4.

MLA (9th ed.) Citation

T, Ikoma, et al. "Safety of Immune Checkpoint Inhibitors in Patients Aged over 80 Years: A Retrospective Cohort Study." Cancer Immunology, Immunotherapy : CII, vol. 73, no. 7, 2024, p. 126, https://doi.org/10.1007/s00262-024-03707-4.